Cross Cultural Validation of the Italian Version of the Clinical Assessment of Dysphagia in Neurodegeneration

Launched by ISTITUTI CLINICI SCIENTIFICI MAUGERI SPA · Feb 8, 2023

Keywords

ClinConnect Summary

This clinical trial is focused on creating and testing an Italian version of a tool called the Clinical Assessment of Dysphagia in Neurodegeneration (CADN). Dysphagia is a condition where people have difficulty swallowing, which can happen in individuals with neurodegenerative diseases like Parkinson's or Alzheimer's. Currently, there isn’t a validated tool in Italian to assess swallowing difficulties in these patients, so this study aims to fill that gap by translating and ensuring that the Italian version works well.

To participate in the trial, individuals must be over 18 years old and have a diagnosed neurodegenerative disease. They should be able to follow simple instructions and sit upright for about 20 minutes during the assessment. However, those with a history of stroke, certain surgeries, or other specific medical conditions may not be eligible. Participants will help researchers understand how well this new tool works, which could ultimately improve care for others facing similar swallowing challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • diagnosis of neurodegenerative disease according to the respective consensus criteria
• • \>18 years old
• • able to provide informed consent
• • able to follow simple instructions
• • capable of sitting upright for anamnesis and examination for at least 20 min (in chair or wheelchair)
• Exclusion Criteria:
• • history of stroke
• • surgery to the head or neck
• • radiotherapy in the last 12 months
• • dysphagia resulting from other known causes